产品名称
Cap B, configured for (ÄKTA® and OligoPilot®)
type
for DNA synthesis
product line
Proligo Reagents
storage condition
dry at room temperature
impurities
≤200 ppm water content (Karl Fischer)
color
clear
suitability
conforms to structure (GC, Formulation)
compatibility
configured for (ÄKTA® and OligoPilot®)
Quality Level
正在寻找类似产品? 访问 产品对比指南
General description
Cap B solution, containing tetrahydrofuran (THF), pyridine and N-methylimidazole (NMI), is mixed in situ with Cap A solution during the capping (acetylation) reaction. Pyridine is applied as a mild base while NMI provides a powerful acylation catalyst.Tetrahydrofurane has been replaced by acetonitrile in ÄKTA Cap B1 and B2.Cap B is configured for ÄKTA formulation.
Other Notes
Cap B2 solution, containing acetonitrile (ACN) and pyridine, is mixed in situ with Cap A and Cap B1 solution during the capping (acetylation) reaction.
Pyridine is applied as a mild base while NMI provides a powerful acylation catalyst.
Pyridine is applied as a mild base while NMI provides a powerful acylation catalyst.
Preparation Note
Acetonitrile / Pyridine 4/6 (v/v)
Legal Information
OligoPilot is a registered trademark of Cytiva
ÄKTA is a registered trademark of Cytiva
signalword
Danger
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2 - Skin Irrit. 2
存储类别
3 - Flammable liquids
wgk
WGK 2
flash_point_f
62.6 °F
flash_point_c
17 °C
法规信息
危险化学品
此项目有
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持